Linked Life Data

21235022

Source:http://linkedlifedata.com/resource/pubmed/id/21235022

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-1-13
pubmed:abstractText
For more than a decade, proteomic techniques have been used to unravel the nature and function of human proteins. In 2002 it came to the attention of clinicians that this technique could be used to discover new biomarkers. However, the first reports were hampered by technical and methodological flaws. Since these first reports, proteomics has matured and the technical abilities have grown enormously. An in-depth analysis of fluid or tissue specimens is now possible. We reviewed recent literature to see whether proteomics has changed our clinical practice in the diagnosis and treatment of gynecological cancers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1473-656X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3-7
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
The utility of proteomics in gynecologic cancers.
pubmed:affiliation
Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Herestraat, Leuven, Belgium. toon.van.gorp@mumc.nl
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't